Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-07 Purchase |
2022-06-08 3:14 pm |
Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director |
27,700 | $0.18 | $4,986 | 32,050 (Direct) |
View |
| 2022-06-07 Purchase |
2022-06-08 3:12 pm |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
37,500 | $0.1871 | $7,016 | 37,500 (Direct) |
View |
| 2022-06-06 Purchase |
2022-06-07 4:33 pm |
Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director |
26,553 | $0.1883 | $5,000 | 26,553 (Indirect) |
View |
| 2022-06-03 Purchase |
2022-06-06 8:33 pm |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
28,000 | $0.184 | $5,152 | 46,350 (Indirect) |
View |
| 2020-08-21 Purchase(A) |
2022-06-06 8:31 pm |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
4,000 | $0.98 | $3,920 | 11,350 (Indirect) |
View |
| 2022-05-26 Purchase |
2022-05-31 5:17 pm |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
43,900 | $0.18188 | $7,985 | 585,248 (Indirect Direct) |
View |
| 2022-05-31 Purchase |
2022-05-31 5:13 pm |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
28,000 | $0.18 | $5,040 | 148,319 (Direct) |
View |
| 2022-03-03 Purchase |
2022-03-09 4:03 pm |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
76,246 | $0.391 | $29,812 | 110,319 (Direct) |
View |
| 2022-03-03 Purchase |
2022-03-09 4:01 pm |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
139,488 | $0.391 | $54,540 | 249,674 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-11 Option Award |
2024-04-12 4:50 pm |
2025-04-11 2034-04-11 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:37 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
22,500 | $0 | 22,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:29 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:25 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:21 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:16 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:13 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 4:09 pm |
2025-02-20 2034-02-19 |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:06 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
6,432 | $0 | 21,851 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:04 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
14,300 | $0 | 49,135 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:12 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
1,440 | $0 | 2,940 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:08 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director |
1,440 | $0 | 1,788 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:06 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | HANISH ARNOLD C Director |
1,440 | $0 | 3,294 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 6:03 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Lammers Paul Director |
1,440 | $0 | 1,718 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:47 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director |
1,440 | $0 | 2,722 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:44 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director |
1,440 | $0 | 2,850 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:35 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
8,000 | $0 | 15,419 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:33 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
20,000 | $0 | 34,835 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-12-12 6:34 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
2,693 | $1.734 | 14,835 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-12-12 6:29 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
1,488 | $1.734 | 7,419 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-11-08 5:42 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
10,000 | $1.734 | 22,142 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-11-08 5:40 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
7,314 | $1.734 | 13,245 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-07 4:34 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
10,000 | $1.734 | 313,574 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-07 4:33 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
7,314 | $1.734 | 155,633 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-05 4:06 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
10,000 | $0.1863 | 259,674 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-05 4:03 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Rosenblum Mark J Exec VP Finance, CFO |
10,000 | $0.1863 | 120,319 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:11 pm |
2023-01-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | McCreedy Bruce J Jr. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:10 pm |
2023-02-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Lieber Jonathan I Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:09 pm |
2023-01-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | McVicar William K. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:08 pm |
N/A 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:07 pm |
2023-01-19 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Burleson Tess Director |
30,000 | $0 | 30,000 (Direct) |
View |